$PLX Protalix BioTherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Protalix BioTherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Protalix BioTherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Protalix BioTherapeutics, Inc. for free.

CIK Number: 0001006281
IRS Number: 650643773
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: PLX
Company Address: 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL 2161401
Former name: EMBASSY ACQUISITION CORP, date of change: 1996-01-24
Former name: ORTHODONTIX INC, date of change: 1998-04-22

Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.

Market Capitalization: $78.10M
Prev close: $0.79
Average Daily Volume: 2,890,240
Days Low: $0.78
Year Low: $0.26
Year High: $0.96

Protalix BioTherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Almon Einat BrillSVP, Chief Development Officer00Jun 08 20201 month ago
Hayon YaelVP, Research & Development00Jul 08 20203 days ago
Schwartz AharonDirector64,00050,560shares bought: 64,000 / shares sold: 0 BUYApr 13 20203 months ago

View all Protalix BioTherapeutics, Inc. insiders.

Protalix BioTherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 08 2020PLXProtalix BioTherap ...Hayon YaelVP, Research & Deve ...Option ExerciseA3.73129,771484,046129,771
Jun 08 2020PLXProtalix BioTherap ...Almon Einat BrillSVP, Chief Developm ...Option ExerciseA3.59196,995707,212196,995
Apr 13 2020PLXProtalix BioTherap ...Schwartz AharonDirectorBuyP2.4364,000155,26464,0000 to 64 K
Feb 05 2020PLXProtalix BioTherap ...Bronfeld ZeevDirectorOption ExerciseA3.70240,000888,000240,000
Jan 22 2020PLXProtalix BioTherap ...Granot DavidDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Bar-Shalev AmosDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Schwartz AharonDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Boudes Pol FDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Melincoff Gwen ADirectorOption ExerciseA3.5540,000142,00040,000
Sep 24 2019PLXProtalix BioTherap ...Rubin EyalSr. VP & CFOOption ExerciseA0.20800,000160,000800,000
Jul 02 2019PLXProtalix BioTherap ...Bashan DrorPresident & CEOOption ExerciseA0.471,600,000750,4001,600,000
Sep 14 2018PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseA0.56700,000392,000700,000
Sep 14 2018PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...Option ExerciseA0.56700,000392,000700,000
Sep 14 2018PLXProtalix BioTherap ...Naos YaronSr. VP, OperationsOption ExerciseA0.56600,000336,000600,000
Sep 14 2018PLXProtalix BioTherap ...Manor MoshePresident & CEOOption ExerciseA0.561,300,000728,0001,300,000

View all Protalix BioTherapeutics, Inc. insider transactions.